Literature DB >> 17003516

Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Lena Serghides1, Mariana Vidric, Tania H Watts.   

Abstract

The generation of strong and specific CD8 T cell responses is important in the control of viral infections. Costimulatory molecules provide signals necessary for the development or maintenance of these responses. A major focus of our laboratory is to investigate the role of costimulatory molecules of the TNFR and CD28 families in antiviral responses. Our aim is to translate information obtained using murine models to the study of these molecules using human cells. We have devised an in vitro system using recombinant replication- deficient adenovirus to deliver costimulatory molecules to antigen-presenting cells that are then used to stimulate autologous T cells from both healthy and HIV-infected individuals. Here we describe our findings and discuss the implications of incorporating costimulatory molecules into viral vector vaccine strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003516     DOI: 10.1385/IR:35:1:137

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  116 in total

Review 1.  Recombinant viruses as tools to induce protective cellular immunity against infectious diseases.

Authors:  Carolina Damas Rocha; Braulia Costa Caetano; Alexandre Vieira Machado; Oscar Bruna-Romero
Journal:  Int Microbiol       Date:  2004-06       Impact factor: 2.479

2.  Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.

Authors:  Mariana Vidric; Woong-Kyung Suh; Umberto Dianzani; Tak W Mak; Tania H Watts
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

3.  Vaccines with enhanced costimulation maintain high avidity memory CTL.

Authors:  Sixun Yang; James W Hodge; Douglas W Grosenbach; Jeffrey Schlom
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

4.  4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.

Authors:  Wojciech Dawicki; Edward M Bertram; Arlene H Sharpe; Tania H Watts
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

5.  Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.

Authors:  Jienny Lee; Eun-Na Lee; Eun-Young Kim; Hae-Jung Park; Chi-Young Chang; Da-Yeon Jung; Su-Young Choi; Suk-Koo Lee; Kwang-Woong Lee; Ghee-Young Kwon; Jae-Won Joh; Sung-Joo Kim
Journal:  Immunol Lett       Date:  2005-11-15       Impact factor: 3.685

6.  Selective induction of high avidity CTL by altering the balance of signals from APC.

Authors:  SangKon Oh; James W Hodge; Jeffrey D Ahlers; Donald S Burke; Jeffrey Schlom; Jay A Berzofsky
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

7.  Costimulation of human CD28- T cells by 4-1BB ligand.

Authors:  Jacob Bukczynski; Tao Wen; Tania H Watts
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532

8.  CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice.

Authors:  Juergen Foell; Simona Strahotin; Shawn P O'Neil; Megan M McCausland; Carolyn Suwyn; Michael Haber; Praveen N Chander; Abhijit S Bapat; Xiao-Jie Yan; Nicholas Chiorazzi; Michael K Hoffmann; Robert S Mittler
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

9.  OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors.

Authors:  Y Ohshima; L P Yang; T Uchiyama; Y Tanaka; P Baum; M Sergerie; P Hermann; G Delespesse
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

10.  Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy.

Authors:  R S Mittler; T S Bailey; K Klussman; M D Trailsmith; M K Hoffmann
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

View more
  2 in total

1.  Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody.

Authors:  Jose F Ponte; Paul Ponath; Reema Gulati; Michael Slavonic; Michael Paglia; Adam O'Shea; Masahide Tone; Herman Waldmann; Louis Vaickus; Michael Rosenzweig
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

2.  The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells.

Authors:  Johanna Kober; Judith Leitner; Christoph Klauser; Ramona Woitek; Otto Majdic; Johannes Stöckl; Dietmar Herndler-Brandstetter; Beatrix Grubeck-Loebenstein; Birgit M Reipert; Winfried F Pickl; Katharina Pfistershammer; Peter Steinberger
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.